NO993225D0 - farnesyl transferase - Google Patents

farnesyl transferase

Info

Publication number
NO993225D0
NO993225D0 NO993225A NO993225A NO993225D0 NO 993225 D0 NO993225 D0 NO 993225D0 NO 993225 A NO993225 A NO 993225A NO 993225 A NO993225 A NO 993225A NO 993225 D0 NO993225 D0 NO 993225D0
Authority
NO
Norway
Prior art keywords
farnesyl transferase
farnesyl
transferase
Prior art date
Application number
NO993225A
Other languages
Norwegian (no)
Other versions
NO993225L (en
Inventor
Jean-Dominique Bourzat
Alain Commercon
Norbert Dereu
Patrick Mailliet
Fabienne Sounigo-Thompson
Jean-Paul Martin
Marc Capet
Michel Cheve
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO993225D0 publication Critical patent/NO993225D0/en
Publication of NO993225L publication Critical patent/NO993225L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/724,7-Endo-alkylene-iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO993225A 1996-12-30 1999-06-29 farnesyl transferase NO993225L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9616206A FR2757855B1 (en) 1996-12-30 1996-12-30 NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1997/002407 WO1998029390A1 (en) 1996-12-30 1997-12-23 Farnesyl transferase inhibitors

Publications (2)

Publication Number Publication Date
NO993225D0 true NO993225D0 (en) 1999-06-29
NO993225L NO993225L (en) 1999-08-24

Family

ID=9499293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993225A NO993225L (en) 1996-12-30 1999-06-29 farnesyl transferase

Country Status (32)

Country Link
EP (1) EP0948483B1 (en)
JP (1) JP2001509147A (en)
KR (1) KR20000062391A (en)
AR (1) AR008950A1 (en)
AT (1) ATE214367T1 (en)
AU (1) AU741921B2 (en)
BR (1) BR9714498A (en)
CA (1) CA2275943A1 (en)
CO (1) CO4920252A1 (en)
CZ (1) CZ233599A3 (en)
DE (1) DE69711081T2 (en)
DK (1) DK0948483T3 (en)
DZ (1) DZ2389A1 (en)
EA (1) EA002114B1 (en)
ES (1) ES2172033T3 (en)
FR (1) FR2757855B1 (en)
HU (1) HUP0001747A3 (en)
ID (1) ID22922A (en)
IL (1) IL130453A0 (en)
MA (1) MA26460A1 (en)
NO (1) NO993225L (en)
NZ (1) NZ336042A (en)
PE (1) PE28199A1 (en)
PL (1) PL334345A1 (en)
PT (1) PT948483E (en)
SK (1) SK88399A3 (en)
TN (1) TNSN97214A1 (en)
TR (1) TR199901502T2 (en)
UY (1) UY24832A1 (en)
WO (1) WO1998029390A1 (en)
YU (1) YU30299A (en)
ZA (1) ZA9711734B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2787327B1 (en) * 1998-12-21 2003-01-17 Aventis Pharma Sa COMPOSITIONS CONTAINING FARNESYL TRANSFERASE INHIBITORS
FR2796641B1 (en) * 1999-07-22 2001-09-21 Aventis Pharma Sa NOVEL PROCESS FOR THE PREPARATION OF BENZOPERHYDROISOINDOLE COMPOUNDS
FR2796640A1 (en) * 1999-07-22 2001-01-26 Aventis Pharma Sa New 3,9-ethano-2,3,3a,4,9,9a-hexahydro-1H-benzo (f) isoindole derivatives, are farnesyl transferase inhibitors useful for treating hyperproliferative disorders, e.g. psoriasis, restenosis or especially cancer
FR2845994B1 (en) * 2002-10-18 2006-05-19 Servier Lab NOVEL SUBSTITUTED BENZO [E] [1,4] OXAZINO [3,2-G] ISOINDOLE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2005089504A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3597863B2 (en) * 1993-11-05 2004-12-08 ワーナー−ランバート・コンパニー Protein: substituted di- and tripeptide inhibitors of farnesyltransferase
FR2736641B1 (en) * 1995-07-10 1997-08-22 Rhone Poulenc Rorer Sa NOVEL FARNESYL TRANSFERASE INHIBITORS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
KR20000062391A (en) 2000-10-25
HUP0001747A3 (en) 2000-10-30
ZA9711734B (en) 1998-06-25
TNSN97214A1 (en) 2005-03-15
AU741921B2 (en) 2001-12-13
DZ2389A1 (en) 2002-12-28
IL130453A0 (en) 2000-06-01
HUP0001747A2 (en) 2000-09-28
SK88399A3 (en) 2000-05-16
JP2001509147A (en) 2001-07-10
CA2275943A1 (en) 1998-07-09
DE69711081T2 (en) 2002-08-01
MA26460A1 (en) 2004-12-20
CO4920252A1 (en) 2000-05-29
WO1998029390A1 (en) 1998-07-09
AR008950A1 (en) 2000-02-23
FR2757855B1 (en) 1999-01-29
ES2172033T3 (en) 2002-09-16
ID22922A (en) 1999-12-16
EP0948483A1 (en) 1999-10-13
BR9714498A (en) 2000-03-21
DK0948483T3 (en) 2002-07-01
PL334345A1 (en) 2000-02-28
AU5669498A (en) 1998-07-31
YU30299A (en) 2002-03-18
DE69711081D1 (en) 2002-04-18
PT948483E (en) 2002-08-30
EA002114B1 (en) 2001-12-24
UY24832A1 (en) 2001-08-27
EP0948483B1 (en) 2002-03-13
ATE214367T1 (en) 2002-03-15
CZ233599A3 (en) 1999-09-15
TR199901502T2 (en) 1999-09-21
FR2757855A1 (en) 1998-07-03
NZ336042A (en) 2000-12-22
EA199900608A1 (en) 2000-02-28
PE28199A1 (en) 1999-06-05
NO993225L (en) 1999-08-24

Similar Documents

Publication Publication Date Title
EE04309B1 (en) Farnesyl protein transferase inhibitors
EE9800408A (en) Protein farnesyl transferase inhibitors
IS4568A (en) Farnesyl protein transferase inhibits
DK0910425T3 (en) catheter Packing
ID17232A (en) HANGER
DE69705949D1 (en) HANGER
DE29602301U1 (en) Packing arrangement
DE69737432D1 (en) Farnesyl diphosphate synthase
DK0948483T3 (en) farnesyl transferase
DE69730216D1 (en) HANGER
DE59711796D1 (en) MORE WAYS VALVE
DK0952768T3 (en) long lines
DE19781785T1 (en) Planters
FI970078A0 (en) planter
FR2754641B1 (en) DISTRIBUTOR
DE69738892D1 (en) hanger
KR970048895U (en) hanger
KR970060215U (en) planter
DE29615663U1 (en) Hanger
UA1337S (en) INSERT
ZA971254B (en) Farnesyl transferase inhibitors
IL155594A0 (en) Farnesyl transferase inhibitors
SI0948483T1 (en) Farnesyl transferase inhibitors
KR970007858U (en) Tie fixture
DE29622050U1 (en) Distributor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application